Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G et al (2016) The genomic landscape of schwannoma. Nat Genet 48:1339–1348. https://doi.org/10.1038/ng.3688

Article  CAS  PubMed  Google Scholar 

Alkaslasi MR, Piccus ZE, Hareendran S, Silberberg H, Chen L, Zhang Y et al (2021) Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord. Nat Commun 12:2471. https://doi.org/10.1038/s41467-021-22691-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z et al (2009) Neurofibromatosis type 2. Lancet 373:1974–1986. https://doi.org/10.1016/S0140-6736(09)60259-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett TF, Patel B, Khan SM, Mullins RDZ, Yim AKY, Pugazenthi S et al (2024) Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state. Nat Commun 15:478. https://doi.org/10.1038/s41467-023-42762-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baruah P, Mahony C, Marshall JL, Smith CG, Monksfield P, Irving RI et al (2024) Single-cell RNA sequencing analysis of vestibular schwannoma reveals functionally distinct macrophage subsets. Br J Cancer 130:1659–1669. https://doi.org/10.1038/s41416-024-02646-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL et al (2023) Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nat Commun 14:1559. https://doi.org/10.1038/s41467-023-37226-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coffin SL, Durham MA, Nitschke L, Xhako E, Brown AM, Revelli JP et al (2023) Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1. Neuron 111:915. https://doi.org/10.1016/j.neuron.2023.02.030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dewan R, Pemov A, Kim HJ, Morgan KL, Vasquez RA, Chittiboina P et al (2015) Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro Oncol 17:566–573. https://doi.org/10.1093/neuonc/nou317

Article  CAS  PubMed  Google Scholar 

Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP et al (2012) Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg 117:109–117. https://doi.org/10.3171/2012.3.JNS111649

Article  PubMed  PubMed Central  Google Scholar 

Evans DG, Hartley CL, Smith PT, King AT, Bowers NL, Tobi S et al (2020) Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing. Genet Med 22:53–59. https://doi.org/10.1038/s41436-019-0598-7

Article  CAS  PubMed  Google Scholar 

Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers NL, Huson SM et al (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44:424–428. https://doi.org/10.1136/jmg.2006.047753

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forde C, King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR et al (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23:1113–1124. https://doi.org/10.1093/neuonc/noaa284

Article  CAS  PubMed  Google Scholar 

Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H et al (2017) Genetic Severity Score predicts clinical phenotype in NF2. J Med Genet 54:657–664. https://doi.org/10.1136/jmedgenet-2017-104519

Article  CAS  PubMed  Google Scholar 

Helbing DL, Schulz A, Morrison H (2020) Pathomechanisms in schwannoma development and progression. Oncogene 39:5421–5429. https://doi.org/10.1038/s41388-020-1374-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Liang X, Xuan Y, Geng C, Li Y, Lu H et al (2017) A reference human genome dataset of the BGISEQ-500 sequencer. Gigascience 6:1–9. https://doi.org/10.1093/gigascience/gix024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo Z, Wang Z, Luo H, Maimaitiming D, Yang T, Liu H et al (2024) Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma. Neuro Oncol 26:444–457. https://doi.org/10.1093/neuonc/noad201

Article  CAS  PubMed  Google Scholar 

Karajannis MA, Legault G, Hagiwara M, Ballas MS, Brown K, Nusbaum AO et al (2012) Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol 14:1163–1170. https://doi.org/10.1093/neuonc/nos146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karajannis MA, Legault G, Hagiwara M, Giancotti FG, Filatov A, Derman A et al (2014) Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol 16:292–297. https://doi.org/10.1093/neuonc/not150

Article  CAS  PubMed  Google Scholar 

Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE et al (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109–114. https://doi.org/10.1136/jmg.40.2.109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewis D, Donofrio CA, O’Leary C, Li KL, Zhu X, Williams R et al (2021) The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. J Neurosurg 134:1419–1429. https://doi.org/10.3171/2020.3.JNS193230

Article  PubMed  Google Scholar 

Lewis D, Roncaroli F, Agushi E, Mosses D, Williams R, Li KL et al (2019) Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma. Neuro Oncol 21:314–325. https://doi.org/10.1093/neuonc/noy177

Article  PubMed  Google Scholar 

Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC et al (2024) Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476. https://doi.org/10.1038/s41467-023-40408-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lloyd SK, Evans DG (2013) Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol 115:957–967. https://doi.org/10.1016/B978-0-444-52902-2.00054-0

Article  PubMed  Google Scholar 

Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141:101–116. https://doi.org/10.1007/s00401-020-02230-x

Article  CAS  PubMed  Google Scholar 

Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ et al (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460–468. https://doi.org/10.1227/01.NEU.0000255340.26027.53. (discussion 468-470)

Article  PubMed  Google Scholar 

Meng F, Yu Z, Zhang D, Chen S, Guan H, Zhou R et al (2021) Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell 81(4147–4164):e4147. https://doi.org/10.1016/j.molcel.2021.07.040

Article  CAS